Cytopoint 40 mg

40mg Cytopoint is indicated for the treatment of clinical manifestations of atopic dermatitis in dogs. Pack of 2 Vials

Cytopoint solution for injection for dogs

Species: Dogs Therapeutic indication: Immunological veterinary medical product (non vaccine): For dogs Active ingredient: Monoclonal antibody (Lokivetmab) Presentation Each Cytopoint vial of 1 ml contains 10, 20, 30 or 40 mg Lokivetmab. Lokivetmab is a caninised monoclonal antibody expressed through recombinant techniques in Chinese hamster ovary (CHO) cells. Uses: Cytopoint is indicated for the treatment of clinical manifestations of atopic dermatitis in dogs. Dosage and administration For subcutaneous use. Avoid excessive shaking or foaming of the solution. Administer the entire contents (1 ml) of the Cytopoint vial. For dogs above 40 kg, the contents of more than one vial of Cytopoint are required to administer in a single dose. In those cases, withdraw the appropriate content from each required vial into the same syringe. To allow for mixing of the solution, gently invert the syringe three or four times before administering. Dosage and treatment schedule The recommended minimum dose is 1 mg/kg bodyweight, once a month.  

Cytopoint 30 mg

30mg Cytopoint is indicated for the treatment of clinical manifestations of atopic dermatitis in dogs. Pack of 2 Vials

Cytopoint solution for injection for dogs

Species: Dogs Therapeutic indication: Immunological veterinary medical product (non vaccine): For dogs Active ingredient: Monoclonal antibody (Lokivetmab) Presentation Each Cytopoint vial of 1 ml contains 10, 20, 30 or 40 mg Lokivetmab. Lokivetmab is a caninised monoclonal antibody expressed through recombinant techniques in Chinese hamster ovary (CHO) cells. Uses: Cytopoint is indicated for the treatment of clinical manifestations of atopic dermatitis in dogs. Dosage and administration For subcutaneous use. Avoid excessive shaking or foaming of the solution. Administer the entire contents (1 ml) of the Cytopoint vial. For dogs above 40 kg, the contents of more than one vial of Cytopoint are required to administer in a single dose. In those cases, withdraw the appropriate content from each required vial into the same syringe. To allow for mixing of the solution, gently invert the syringe three or four times before administering. Dosage and treatment schedule The recommended minimum dose is 1 mg/kg bodyweight, once a month.